

"Currently we have well over 100 products on the market and the cardiovascular portfolio is one of the main drivers that generate growth for the company. Looking to the future, we are working to expand into the oncology market."
Ravinder S. Singha, the Managing Director of Firmlink Pharma, discusses the unique business model they offer to their clients, their key success factors in entering new and sometimes challenging markets,…
Ramon Aristoza, acting President and CEO of PhilHealth, discusses the current challenges the organization is facing in terms of realizing the goal of universal healthcare for the Filipino population, their…
Jingle Garcia Diola, Executive Director at Firmlink Pharma, details the company’s value-added services and how they are positioning themselves as the business development partner of choice for large local and…
See our Cookie Privacy Policy Here